Evaluating Photodynamic Therapy vs. Subthreshold Micropulse Laser for Central Serous Chorioretinopathy: A Retrospective Study. Vergleich von photodynamischer Therapie mit Subthreshold-Micropulse-Lasertherapie bei Chorioretinopathia centralis serosa.
Authors: Spitznagel, T., Fasler, K., Zoellin, J., Gunzinger, J. M., Sommer, C., Kinzl, S., Muth, D. R., Turgut, F., Saad, A., Becker, M., Somfai, G. M., & Zweifel, S.
Presented: January 1, 2025
Type: Publications
Conclusion: Both PDT and SML demonstrated improvements in SRF, CST and VA, with SML presenting as a comparable alternative, particularly in cases where access to verteporfin is limited.
Related publications and webinars
- The treatment strategy and selected parameters presented in content listed here are solely the responsibility of the treating ophthalmologist, who is required to be familiar with the most recent literature/guidelines or recommendations, as well as with the usage of the Navilas Laser System according to the current Operator’s Manual.